1531 - 1540 of 6452 Results
Title
Year
-
OPENTitle: Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changesJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 1Start Page: 337End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-10163-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7855683Citation Count: 18
-
OPENTitle: Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1566End Page: 1573Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10730-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10730-3.pdfCitation Count: 14
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 49
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 60
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 39
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 648417End Page: 648417Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648417/pdfCitation Count: 11
- Mapping microstructural gradients of the human striatum in normal aging and Parkinson’s disease2022OPENTitle: Mapping microstructural gradients of the human striatum in normal aging and Parkinson’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 28Start Page: eabm1971End Page: eabm1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abm1971Best OA location URL: https://doi.org/10.1126/sciadv.abm1971Citation Count: 51
- Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B2023OPENTitle: Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55BJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 50Start Page: eadj1205End Page: eadj1205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adj1205Best OA location URL: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/Lipofectamine_RNAiMAX_Reag_protocol.pdfCitation Count: 34
-
OPENTitle: The vermiform appendix impacts the risk of developing Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280Best OA location URL: https://hal.science/hal-04247698Citation Count: 275